57th. Annual National Conference of Indian Society of Anaestbesiologists 2009 Chennai, India 26 - 30 Dis ember 2009.
Loading...
Date
2009
Authors
Gnandev, Pbutane
Journal Title
Journal ISSN
Volume Title
Publisher
Pusat Pengajian Sains Perubatan
Abstract
Background end goals of study. to evaluate the eflicacy,safety,tolerability & side effect between of pregabalin, gabapentin and topiramate in chronic pain management Methods: Prospective, double blind,randomized controlled trial of 12 weeks duration comparing pregabalin, gabapentin & topiramate. Study was conducted on patient with chronic pain clinic at LLRH, Kanpur. Participants were 120 patients with chronic pain. Tha primary outcome was difference between pregabalin, gabapentine & topiramate in chronic pain, as measured by the mean VAS score computed over weekly of each treatment period.Secondary outcomes were changes in mood, quality of life & psychomotor functions.Side effects were measured by questionnaire. Patient received a maximum dally dose of 600 mg gabapentine or 400 mg pregabalin or 1 00 mg topiramate along with 300 mg aceclofenac Results: Mean baselineVAS was 69.6 mm (29.4-95.2) on a scale of 0-100mm.120 patients were included in the available case analysis & 30 patients in the per protocol analysis. The mean score was 6mm longer for gabapentine than for pregabalin & topiramate in the available case analysis & 5.6 mm in the per protocol analysis. Cone/us/on: Gabapentine provided better pain relief than the pregabalin & topiramate & had slightly fewer side effects, well tolerable, although no major adverse events occur for either drug.